• "It takes about 2 x as long for someone with MS to absorb and process information as someone who does not have MS: Back to School With MS? Here's How"
• Multiple Sclerosis Treatment Options: Breakdown of Associated Risks
• Study: Tysabri (Natalizumab) to fingolimod washout in patients at risk of PMLFingolimod, Tysabri
• Neil Cavuto on Feeling Moved to Tell His Viewers: ‘It’s Not Me, It’s The Multiple Sclerosis’
• Merck KGaA shores up Rebif defenses to fend off new MS rivalsRebif
• Play the MS Matching Game: brain games can help exercise your mind
• Survey showed strong uptake of the new 40-milligram, thrice-weekly version of Teva's Copaxone, estimating that about 40% of MSers will have switched to it after two yearsCopaxone
• New warning suggested for Ambien...the same sleeping pill that landed a Kennedy before a jury: says patients shouldn't drive for 8 hours after they take meds like Ambien
• $15 Million awarded to former Newark teacher with MS who says district retaliated against her
• A Glittering Rock Reunion of 14,300 Fans Becomes the Best of Get-Well Gifts for Guitarist Ronnie Lane
• Study: 2014 Multiple Sclerosis Therapeutic Update, UCSF MS Department of Neurology, San Francisco, CA
• Study: High prevalence and no latitude gradient of multiple sclerosis in Norway
• Study: Supervised exercise training has substantial benefits for MSers, yet 80% of those with MS do not meet recommended levels of moderate-to-vigorous physical activity (MVPA)
• "British Health Minister Edwin Poots witnessed first-hand how oxygen therapy can help MSers enjoy a better quality of life"
• Illinois lottery game fund multiple sclerosis research
• BREAKING NEWS! WARNING: Pfizer Issues Nationwide Recall of Antidepressant Effexor
• For Runner With M.S., No Pain While Racing, No Feeling at the Finish (New York Times)
• A MSer's story of how she & her Neuro both had problems with Anthem BlueCross getting her MS treatment refilled:10 BEST
• Doctors’ #1 Source for Healthcare Information: Wikipedia
• Merck KGaA shores up Rebif defenses to fend off new MS rivals
• Novartis, Sanofi, Biogen tout new MS drug researchAubagio, Copaxone, Gilenya, Tysabri
• My recent struggles made me realize, you only live life one time
• "Innate Immunotherapeutics delivered results from animal studies which further support its novel MIS416 therapy as a candidate to treat Secondary Progressive Multiple "Sclerosis (SPMS)
• Oregon Health & Science University today announced the creation of the OHSU Center for Embryonic Cell and Gene Therapy, led by Shoukhrat Mitalipov, Ph.D., a world-renowned leader in embryonic stem cell and gene therapy research
• Study: Neglecting data from individuals with MS who exhibit head movement during functional magnetic resonance imaging (fMRI) scanning may bias sampling away from individuals with lower cognitive ability
• Study: MiR-126: a novel route for Tysabri (natalizumab) action?Tysabri
• "Dr. Monson has developed a validated method for pre-testing people living with MS to determine if they are a carrier of a unique antibody gene that leads to the disease, thus mitigating the long-standing challenge of diagnosis"
• MS trial to explore vitamin D links
• Study: Oxygen Cost of Walking in Persons with Multiple Sclerosis: Disability Matters, but Why?
• A SAD BUT IMPORTANT LESSON FOR ALL MSers: "Inquest hears how MSer dropped match or cigarette onto her bed that engulfed her in flames and burnt down her home
• This MSer believes marijuana helped put his MS in remission: soon however, Davidson will be forced to destroy the medicine he credits with saving his life
• Biogen Idec finished 2013 on a high note, with its highly touted oral multiple sclerosis drug Tecfidera producing nearly $400 million in sales during the fourth
• Study Findings from Biogen Idec, Inc. Provide New Insights into Multiple Sclerosis
• Slightest change makes myelin come unglued: One common characteristic of diseased myelin is swelling due to MS
• OMG of the week: Doctors flee homes after declaring strike
• What Do Healthcare Providers Advise Women with Multiple Sclerosis Regarding Pregnancy?
• How Inactivity Change MSer's Brains
• One-liners may hint at feelings about health care
• RUNNING HELPS ME MANAGE MY MS: Jeanine Parson
• I'm a mother of 3 young children and here's my horror story of my MS & the new health care law
• TAKEDA ADMITS TO IMPROPERLY MARKETING BLOCKBUSTER DRUG a AFTER DOCTOR POINTS OUT DATA IN AD DIDNT MATCH RESULTS OF CLINICAL STUDY
• Study: “Bright spotty lesions” on spinal magnetic resonance imaging differentiate neuromyelitis optica from multiple sclerosis
• Clues To Causes Of Nerve Cell Degeneration in MS Provided By Spasticity Gene Finding
• Minn. physicians ponder medical pot: Is marijuana an effective treatment for pain, illness and disease?
• Study: MRI evaluation of grey matter atrophy and disease course in multiple sclerosis: an overview of current knowledge
• Variables associated with patient activation in persons with multiple sclerosis
• What Vitamin D Dosage Do I need? How Much Sun Do I Need?
• Optical coherence tomography and visual evoked potentials: which is more sensitive in multiple sclerosis?
• Express Scripts stops covering older, commonly used treatments such as Bayer's multiple sclerosis drug Betaseron on clinical, cost-effectiveness grounds
• Study: Antiviral drug Ganciclovir Inhibits Neuroinflammation in Mouse Model of MS
• Myelin basic protein-diverse conformational states of an intrinsically unstructured protein and its roles in myelin assembly and multiple sclerosis
• Study: Constraint-induced movement therapy increased neuroplasticity in MS patients according to MRI findings, whereas massage, yoga, and other "complementary/alternative medicine" treatments did not.
• Arshiya’s special talent: I used to jump all the way down the steps in Hodge Lee in one leap. I felt like Superman, or rather, Superwoman. That was before I got MS
• TEVA'S COPAXONE PATENT IS UP AND ITS DESPERATE TO KEEP PATIENTS & INSURERS
• DOES THIS NEW STUDY MEAN ANYTHING FOR MS PATIENTS?: "Medical Marijuana: Studies Find No Benefit for RA: Rheumatologists should not currently be recommending the use of medical marijuana to their patients for relief of chronic pain, researchers stated
• 4 Things All Doctors Need To Know About Health IT Security
• Video: THE SCANDAL THAT ROCKED THE PATIENT SAFETY MOVEMENT BREAK...
• CAN CAFFEINE HELP AN MSers MEMORY: Caffeine’s little memory jolt garners a lot of excitement
• Air Force Academy's future rests in Lt. Gen. Michelle Johnson steady hands: the institution's first female superintendent, has been tearing down barriers all her life including MS
• Senate Passes Casey MS Resolution Ahead of Multiple Sclerosis Awareness Week
• "MS doesn't define us - it's just there"
• 7 women are suing Doctor & health network for medical negligence, claiming the doctor misdiagnosed them with multiple sclerosis
• "My 1st experience as an immunologist diagnosed with MS" by Griselda Zuccarino-Catina, PH.D.
• DOCTORS BEDSIDE MANNER: written by a doctor
• Immunophenotyping Separates MS Subtypes by Neuroinflammation
• What's new in the fight against MS? USA Today
• Another big beast joins the MS Drug fray: ofatumumab phase 2 trial results
• MSnewsChanel.com.com
• Study may provide future insights into causes and mechanisms of MS
• 30% of the 16,651 people who died of an opioid overdose also had taken a benzodiazepine
• Working as a full time police officer & living with MS
• Here's 5 ways to help ease the pain of winter months
• Obamacare Hikes Cost to Patients of Specialty Drugs for MS
• The battle of a 6th grader recently diagnosed with MS
• Study: Stethoscopes carry more bacteria, such as Methicillin-resistant Staphylococcus aureus (MRSA), than a physician’s hand
• Merck's Rebif is a 3rd major MS drug to be discovered in Israel: The Israeli Connection
• Kristen discovers running as way to combat her MS
• Cara Therapeutics has exciting new MS drugs in their pipeline
• Study: See One, Do One: Watching Action Boosts Brain Volume, Ability
• Study: Graph theoretical analysis indicates cognitive impairment in MS stems from neural disconnection
• We've posted 314 Studies & Stories for you so far this week
• FOR DOCTORS ONLY: 15 Smartphone Apps to Improve Your PracticeDocs Only
• WEEKEND LOL REPORT: Medical School Limiting the Number of Creepy Applicants to Cut Down on Creepy Doctors
• Video: 'Dallas Buyers Club' connects with MSers
• FOR DOCTORS ONLY: Study Companion: Mastering Clinical Concepts in MS Management

Labels: Aubagio, Copaxone, Gilenya, Rebif, Rituxan-Rituximab, TECFIDERA, Tysabri